Research Paper Volume 16, Issue 9 pp 8171—8197
Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma
Figure 10. LRRC59 knockdown rendered HCC cells more sensitive to immunotherapy. (A) Heatmap of various cytokines and chemokines detected by ProcartaPlex multiple immunoassays between LRRC59 knockdown and the negative control groups in SNU387 cell culture supernatants. (B, C) The levels of some chemokines detected using ELISA between LRRC59 knockdown and the negative control groups in SNU-387 and SNU-449. (D–G) T cell-mediated tumor cell-killing assay between LRRC59 knockdown and negative control groups in SNU-387 and SNU-449.